Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of obatoclax mesylate in Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Obatoclax Mesylate (obatoclax mesylate)

Snippet

Sponsor: Gemin X | Conditions: Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED